Our Company
About Us
Leadership
Founders
Board of Directors
Our Approach
The Untapped Opportunity
Product Engine
Targeting Metabolic Pathways to Tune Immune Cells
Our Therapeutic Focus
Therapeutic Focus
Our Workplace
Our Team
Careers
News
Press Releases
Contact
Contact Us
A NEW SETPOINT
for immunometabolism
Translating insights in
immunometabolism
into a novel class of treatments for patients with severe immune-mediated diseases and cancer
A NEW SETPOINT
for immunometabolism
Translating insights in
immunometabolism
into a novel class of treatments for patients with severe immune-mediated diseases and cancer
See how
tuning immune cell function
by targeting metabolic pathways is a powerful therapeutic lever.
Our
product engine
drives the Rheos difference: a systems-level approach to mapping the “ImmunoMetabolome”
October 10, 2018
Rheos Medicines Expands Leadership Team with Appointments of Gad Soffer as Chief Operating Officer and J. Duncan Higgons to Board of Directors
